Document is current
Any future updates will be listed below
-
Authors
Combet, Emilie https://orcid.org/0000-0002-9302-8971
Haag, Laura https://orcid.org/0000-0003-3342-1365
Richardson, Janice
Haig, Caroline E.
Cunningham, Yvonne
Fraser, Heather L.
Brosnahan, Naomi
Ibbotson, Tracy
Ormerod, Jane
White, Chris
McIntosh, Emma
O’Donnell, Catherine A.
Sattar, Naveed https://orcid.org/0000-0002-1604-2593
McConnachie, Alex https://orcid.org/0000-0002-7262-7000
Lean, Michael E. J. https://orcid.org/0000-0003-2216-0083
Blane, David N. https://orcid.org/0000-0002-3872-3621
-
Funding
Funding for this research was provided by:
DH | National Institute for Health Research (COV-LT2-0059, COV-LT2-0059, COV-LT2-0059, COV-LT2-0059, COV-LT2-0059, COV-LT2-0059, COV-LT2-0059, COV-LT2-0059, COV-LT2-0059, COV-LT2-0059, COV-LT2-0059, COV-LT2-0059, COV-LT2-0059, COV-LT2-0059, COV-LT2-0059, COV-LT2-0059)
- License Information
-
More Information
Article History
Received: 24 June 2024
Accepted: 30 October 2024
First Online: 8 January 2025
Competing interests
: N.B. is an employee and shareholder of Counterweight Ltd, subcontracted to the University of Glasgow to deliver the ReDIRECT intervention. A.M. is a member of Clinical Steering Committee for ARC Medical Inc. N.S. has received institutional grant support from AstraZeneca, Boehringer Ingelheim, Novartis and Roche Diagnostics and honoraria from Abbott Laboratories, AbbVie, Afimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Janssen, Menarini-Ricerche, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer, Roche Diagnostics and Sanofi. M.E.J.L. has received lecturing fees from Novo Nordisk, Eli Lilly, Nestle and Sanofi and is a medical advisor to Counterweight Ltd, with fees paid to the University of Glasgow. J.O. and C.W. are members of the Long Covid Scotland charity. The other authors declare no competing interests.
